Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...

Pericarditis III: Medical Management

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Pericarditis I: Introduction

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...

Pericarditis IV: Nursing Management

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.

Myocarditis IV: Nursing Management

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hydroxychloroquine for recurrent pericarditis: Old drug, new role.

European journal of internal medicine·2026

Same author

Navigating the Spectrum of Inflammatory Myocardial and Pericardial Syndromes: A Contemporary Approach to Diagnosis and Management.

Journal of cardiac failure·2026

Same author

Perioperative Continuation of Interleukin-1 Blockade in Chronic Constrictive Pericarditis: Imaging-Guided Surgical Decision.

JACC. Case reports·2026

Same author

How to Use Multimodality Imaging for Pericarditis.

Circulation. Cardiovascular imaging·2026

Same author

Infliximab-induced lupus with recurrent pericarditis: longitudinal CMR assessment of inflammatory resolution.

The international journal of cardiovascular imaging·2026

Same author

Evolving Guidelines in Pericarditis: Aligning Practice With Pathophysiology.

JACC. Advances·2026

Search research articles

Related Experiment Videos

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers

Patrick Creechan¹, Jonathan Salik², Brittany Weber³

¹Pericardial Disease Program, MedStar Georgetown University Hospital, Washington, DC, USA.

Journal of Cardiovascular Pharmacology

|June 26, 2026

Summary

Interleukin-1 blockers are increasingly used for recurrent pericarditis. Expert opinion guides counseling on infection risk, activity, and lifestyle for these patients.

Keywords:

Recurrent pericarditis immunosuppression interleukin-1 restriction screening

Related Experiment Videos

Area of Science:

Cardiology
Immunology
Pharmacology

Background:

Recurrent pericarditis treatment landscape is evolving.
Interleukin-1 blockers are gaining traction for refractory cases.
Clinical questions regarding safety and management have emerged.

Purpose of the Study:

To provide expert opinion on managing patients on interleukin-1 blockers for recurrent pericarditis.
To guide clinical decision-making and patient counseling.
To address practical considerations in the evolving therapeutic context.

Main Methods:

Expert consensus and opinion synthesis.
Review of clinical practice challenges.
Development of counseling points.

Main Results:

Identification of key areas for patient counseling.
Framework for clinical decision-making regarding infection risk.
Guidance on activity and lifestyle modifications.

Conclusions:

Patient counseling is crucial for interleukin-1 blocker therapy in recurrent pericarditis.
Addressing infection risk, activity, and lifestyle is essential for optimal outcomes.
Expert opinion provides valuable guidance in this developing area of treatment.